WHO stops testing hydroxychloroquine as a drug for coronavirus

The decision to terminate the test was made after the intermediate results showed that the level

mortality rates of patients hospitalized withcoronavirus after taking the antimalarial drug, practically did not decrease. WHO also stopped testing two other drugs - lopinavir and ritonavir. Doctors admitted that the reduction in patient mortality was negligible or even absent.

National Institute of Health alsosuspended the hydroxychloroquine test after the study showed no harm or benefit from the use of the antimalarial drug for hospitalized patients with COVID-19.

The new COVID-19 strain multiplies and is transmitted faster. We tell everything that is known about him

Referring to safety concerns andthe US Food and Drug Administration (FDA) has revoked the emergency use of antimalarial hydroxychloroquine and chloroquine drugs.

Senior Researcher, Office ofUS Food and Drug Administration Denise Hinton noted that the agency will not allow prescribing the drug to hospitalized patients with COVID-19 or use it in clinical trials. Officials said both drugs are "unlikely to be effective."

In Russia, two drugs for the treatment of coronavirus are registered - avifavir and levilimab (trade name "Ilsira").

Read also

- It turned out that made the Mayan civilization leave their cities

- On day 3 of illness, most patients with COVID-19 lose their sense of smell and often suffer from a runny nose

- Look at the bare core of a giant planet: scientists have found this for the first time.